Trial Profile
Patient Satisfaction after Switching to Paroxetine CR: A Follow-up Study Using HSDS/HSAS (Himorogi Self-rating Depression/Anxiety Scale)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Paroxetine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Therapeutic Use
- 02 Jul 2013 New trial record